Economic Evaluation of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease

2010365 citationsJournal Article

Authors

William F. Fearon · Stanford Medicine

Bernhard Bornschein · Radboud University Nijmegen

Pim A.L. Tonino · Radboud University Nijmegen

Raffaella Matteucci Gothe · Catharina Ziekenhuis

Bernard De Bruyne · Catharina Ziekenhuis

Nico H.J. Pijls · Catharina Ziekenhuis

Uwe Siebert ·

Abstract

Economic evaluation of the FAME study reveals that FFR-guided percutaneous coronary intervention in patients with multivessel coronary disease is one of those rare situations in which a new technology not only improves outcomes but also saves resources. Clinical Trial Registration- URL: http://ClinicalTrials.gov. Unique identifier: NCT00267774.

Topics & Keywords

Coronary Interventions and Diagnostics Peripheral Artery Disease Management Health Systems, Economic Evaluations, Quality of Life

Publication Details

Published in: Circulation

Volume 122, Issue 24, pp. 2545-2550

DOI: 10.1161/circulationaha.109.925396

Field-Weighted Citation Impact: 26.69

Command Palette

Economic Evaluation of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease

Authors

Abstract

Topics & Keywords

Publication Details